John Norrie

University of Edinburgh

Papers

1

Total Citations

14

H-Index

1

About

John Norrie is a leading clinical trialist and biostatistician whose work has profoundly shaped evidence-based medicine, particularly in perioperative care and chronic disease management. His research focuses on the design, conduct, and analysis of large-scale randomised controlled trials, with major contributions to understanding interventions that improve surgical recovery and patient outcomes. Among his most cited works is the landmark ALLEGRO trial (2022), a placebo-controlled randomised study demonstrating that intravenous lidocaine can accelerate gastrointestinal recovery after colorectal surgery—a finding that directly addresses the 40% of patients who suffer delayed return of GI function. This trial, with 14 citations, exemplifies Norrie’s skill in translating rigorous methodology into clinically actionable results. His broader portfolio includes influential trials in cardiovascular disease, diabetes, and respiratory medicine, many of which have informed international guidelines. With a career spanning decades, Norrie has co-authored hundreds of papers, accumulating thousands of citations, and has been instrumental in advancing trial efficiency through innovative statistical approaches. His work is essential reading for researchers seeking to understand how robust trial design can solve real-world surgical and medical challenges.

Research Focus

Key Achievements

1
H-Index
1
Papers
14
Total Citations
14
Avg Citations/Paper
🏆 Most Cited Paper
The ALLEGRO trial: a placebo controlled randomised trial of intravenous lidocaine in accelerating gastrointestinal recovery after colorectal surgery
14 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Edinburgh

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago